Given the pivotal role of PD-L1 in negatively influencing the immune response of effector T cells, HCC cells were treated with chrysin to investigate whether chrysin could impair the PD-1/PD-L1 axis for expanding the anti-cancer immunity potency of T cells [41]. Here, PDCD1 is linked to hepatocellular carcinoma.